About Dynoma
Building Technologies for Dynamic Biology
Dynoma Biosciences is a Canadian biotechnology company developing innovative research platforms and molecular technologies to explore the dynamic nature of biology.
Biological systems are not static. Nucleic acid continuously changes its structure and accessibility, proteins transition between functional states, and biomolecules form transient interactions that regulate cellular behavior. These dynamic processes are fundamental to gene regulation, cellular adaptation, disease development, and therapeutic response. Yet many conventional approaches provide only static snapshots of these events
At Dynoma Biosciences, we are developing technologies designed to capture, map, and ultimately manipulate these dynamic molecular states.
Our work focuses on alternative DNA structures, DNA and RNA dynamics, protein–nucleic acid interactions, protein dynamics, protein–protein interactions, and cellular processes. By developing new ways to interrogate these mechanisms, we aim to uncover previously inaccessible aspects of biology and translate these discoveries into opportunities for therapeutic target identification, drug discovery, and biotechnology development.
Our Vision
From Molecular Dynamics to Discovery
Our vision is to advance biotechnology from observing biological molecules primarily as static structures toward understanding and controlling their dynamic states, interactions, and transitions.
DNA and proteins can adopt multiple structural and functional states depending on their molecular environment. These transitions can influence transcription, genome stability, signaling, metabolism, stress responses, and disease-associated pathways.
We believe that technologies capable of identifying and manipulating these dynamic states can reveal a new layer of biological information and provide new opportunities for therapeutic intervention.
Dynoma is building research platforms at the intersection of molecular biology, genomics, protein science, chemical biology, and drug discovery to explore this emerging landscape.
Our Mission
Turning Molecular Discoveries into Transformative Medicines
At Dynoma Biosciences, our mission is to advance biomedical innovation by developing cutting-edge research platforms and pioneering therapeutic discovery programs.
We focus on understanding and harnessing complex biomolecular interactions, alternative nucleic acid structures, RNA biology, and cellular pathways to uncover new therapeutic opportunities.
By bridging fundamental research with drug discovery, we strive to translate scientific insights into transformative technologies and next-generation medicines.
Driven by scientific excellence, creativity, and collaboration, we are committed to developing innovative tools that empower researchers, accelerate the identification of promising drug candidates, and address unmet medical needs.
Through the integration of molecular biology, biotechnology, and advanced drug discovery approaches, we aim to build a pipeline of breakthrough innovations with the potential to make a meaningful impact on human health.
Scientific Advisors
Professor, Department of Biochemistry and Molecular Biology (Primary appt.), Department of Physiology and Biophysics (Cross appt.), Dalhousie University
Adjunct Professor, University of New Brunswick
Affiliate Scientist, Saint John Regional Hospital
Dalhousie Medicine New Brunswick (DMNB)
INQUIRIES
© 2026 Dynoma Biosciences Inc. All rights reserved.
